BusinessTetraphase Pharmaceuticals to Present at Roth Conference 2016By Nasdaq OMXMar 10, 2016, 2:10 PM UTC
BusinessMelinta Therapeutics Appoints John Temperato President and Chief Operating OfficerBy Nasdaq OMXFeb 23, 2016, 1:00 PM UTC
BusinessMelinta Therapeutics Initiates Phase 3 Study of Baxdela in Hospital-Treated Community-Acquired Bacterial PneumoniaBy Nasdaq OMXJan 6, 2016, 1:00 PM UTC
